Long Term Investments - Cartesian Therapeutics Inc (NASDAQ:RNAC) - Alpha Spread

Cartesian Therapeutics Inc
NASDAQ:RNAC

Watchlist Manager
Cartesian Therapeutics Inc Logo
Cartesian Therapeutics Inc
NASDAQ:RNAC
Watchlist
Price: 16.54 USD 5.82% Market Closed
Market Cap: 353.6m USD
Have any thoughts about
Cartesian Therapeutics Inc?
Write Note

Cartesian Therapeutics Inc
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cartesian Therapeutics Inc
Long-Term Investments Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Cartesian Therapeutics Inc
NASDAQ:RNAC
Long-Term Investments
$2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Long-Term Investments
$272m
CAGR 3-Years
1%
CAGR 5-Years
-29%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
Long-Term Investments
$376m
CAGR 3-Years
-23%
CAGR 5-Years
-34%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Long-Term Investments
$4.5B
CAGR 3-Years
497%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Long-Term Investments
$7.7B
CAGR 3-Years
25%
CAGR 5-Years
22%
CAGR 10-Years
30%

See Also

What is Cartesian Therapeutics Inc's Long-Term Investments?
Long-Term Investments
2m USD

Based on the financial report for Jun 30, 2024, Cartesian Therapeutics Inc's Long-Term Investments amounts to 2m USD.

What is Cartesian Therapeutics Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 1Y
0%

Over the last year, the Long-Term Investments growth was 0%.

Back to Top